Medical Device
Gastrointestinal disorder is a widely prevalent condition and has been estimated to affect thirty million patients in the United States.
Our new multiplexed biosensor device has broad potential for treating a wide range of gastric disorders and gastro-dysfunction symptoms. The device will have the capability to dispense a secure release of drug/medication, pad/patch designed, with specific fixed or combined dosages that can be directly absorbed into the patient's skin.
The device will have a needle-free targeted, drug delivery system to treat or alleviate pain, inflammation and cramping. Our product will offer a fast, reliable, cost effective, drug delivery system to alleviate symptoms associated with Gastrointestinal disorders and improve the quality of life and patient outcomes.
AI and Mobile Health Technology
Our goal is to apply the latest advances in sensor, AI and Mobile Technology to help minimize drug side effects and improve the accuracy and efficiency of medical diagnosis, treatments and therapies.
The device will have potential drug applications that will play a significant role in the optimization of drug delivery. The integration of AI and Mobile technology will offer cutting-edge visualization tools for data integration with a smart, user - friendly interface.
We offer a practical approach to the development of an effective and safe alternative drug delivery method using the latest advances in AI Technology to improve patient's quality of care.
Innovation Technology
Painless, noninvasive, targeted drug/ medication pad or patch delivery system that absorbs into patient's skin.
An alternative to oral drug delivery that is appealing to patients and doctors.
Monitor and records drug doses and alert patient when it's time for next dosage, allowing doctors and healthcare professionals with information and insight and track progress overtime.
The device will allow easy, safe, and effective dose delivery to patients that will enable reversal of gastrointestinal dysfunction symptoms.
Medications can be customized to a wide range of Gastrointestinal Disorders and Gastrointestinal Dysfunction Symptoms.
Needle-free drug delivery system that can be used in an impatient and outpatient setting, home or work.
Platform is customizable and may have future applications in the early detection and drug treatment of intestinal cancers and other diseases.
Our product will improve treatments and therapies and uncover new therapeutic pathways, leading to quality interventions and treatments that will benefit patients, improve diagnosis and patients experience.
Excelolife is interested in fostering additional relationships with members of the Biotechnology and Pharmaceutical Industry for product and commercial development. To learn more about our product, please feel free to e-mail me at: www.products@excelolifepartnership.com.
Our goal is to develop a series of preclincial and clinical trials designed to validate our device, AI technology and its many applications. Our team with bring their expertise in product development, clinical trial design and implementation of therapeutic treatments. We will deliver medical, quality research and research oversight to ensure clinical trials are successfully implemented.
Pharmaceutical Application to treat Gastrointestinal Pain, Inflammation and Cramping
Needle-free Drug Delivery Technology
Preclinical and Clinical Trial Development
